From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on December 20, 2023.
Yantai Zhenghai Biotechnology Co., Ltd.
Equities
300653
CNE100002NZ1
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.01 CNY | +1.50% |
|
-5.28% | -27.60% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.60% | 521M | |
+14.42% | 131B | |
-15.80% | 7.33B | |
+42.18% | 5.69B | |
-20.14% | 4.83B | |
+8.58% | 3.45B | |
-19.51% | 2.47B | |
-17.70% | 1.93B | |
-19.46% | 1.79B | |
-34.15% | 1.52B |
- Stock Market
- Equities
- 300653 Stock
- News Yantai Zhenghai Biotechnology Co., Ltd.
- Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.